Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3509

1.

(18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.

Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.

Hell J Nucl Med. 2011 Sep-Dec;14(3):311-2.

PMID:
22087457
2.

Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.

Ak I, Sivrikoz MC, Entok E, Vardareli E.

Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

PMID:
20015657
3.

Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.

Iagaru A, Mittra E, Dick DW, Gambhir SS.

Mol Imaging Biol. 2012 Apr;14(2):252-9. doi: 10.1007/s11307-011-0486-2.

PMID:
21479710
4.

Pineal gland involvement in Erdheim-Chester disease detected on (18)F-FDG PET-CT imaging: a case report and review of literature.

Mukherjee A, Dhull VS, Karunanithi S, Sharma P, Durgapal P, Kumar R.

Clin Imaging. 2014 May-Jun;38(3):367-71. doi: 10.1016/j.clinimag.2013.12.005. Epub 2013 Dec 21. Review.

PMID:
24461468
5.

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.

J Nucl Med. 2008 Feb;49(2):195-200. doi: 10.2967/jnumed.107.045641. Epub 2008 Jan 16.

6.

Diagnosis of Erdheim-Chester disease by using computerized tomography-guided stereotactic biopsy of a caudate lesion. Case report.

Tashjian V, Doppenberg EM, Lyders E, Broaddus WC, Pavot P, Tye G, Liu AY, Perez J, Ghatak N.

J Neurosurg. 2004 Sep;101(3):521-7.

PMID:
15352612
7.

Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.

Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.

J Nucl Med. 2015 Dec;56(12):1862-8. doi: 10.2967/jnumed.115.162610. Epub 2015 Sep 24.

8.
9.

Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?

Sahin E, Zincirkeser S, Akcan AB, Elboga U.

J BUON. 2014 Jan-Mar;19(1):291-6.

PMID:
24659678
10.

The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.

García-Gómez FJ, Acevedo-Báñez I, Martínez-Castillo R, Tirado-Hospital JL, Cuenca-Cuenca JI, Pachón-Garrudo VM, Álvarez-Pérez RM, García-Jiménez R, Rivas-Infante E, García-Morillo JS, Borrego-Dorado I.

Eur J Radiol. 2015 Aug;84(8):1586-92. doi: 10.1016/j.ejrad.2015.04.022. Epub 2015 Apr 30.

PMID:
25975897
11.

Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.

Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.

Acta Radiol. 2016 Jan;57(1):58-65. doi: 10.1177/0284185114564438. Epub 2014 Dec 22.

PMID:
25533313
12.

Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings.

Antunes C, Graça B, Donato P.

Insights Imaging. 2014 Aug;5(4):473-82. doi: 10.1007/s13244-014-0331-7. Epub 2014 Jul 14.

13.
14.

FDG-PET in the Erdheim-Chester disease: its diagnostic and follow-up role.

Steňová E, Steňo B, Povinec P, Ondriaš F, Rampalová J.

Rheumatol Int. 2012 Mar;32(3):675-8. doi: 10.1007/s00296-010-1676-y. Epub 2010 Dec 7.

PMID:
21136259
15.

Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.

Lee JW, Lee SM, Lee HS, Kim YH, Bae WK.

Ann Nucl Med. 2012 Oct;26(8):627-33. doi: 10.1007/s12149-012-0622-3. Epub 2012 Jun 24.

PMID:
22729551
16.

[Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].

Adam Z, Balsíková K, Krejcí M, Pour L, Stĕpánková S, Svacina P, Hermanová M, Vanícek J, Krupa P, Stanícek J, Koukalová R, Neubauer J, Krivanová A, Mayer J, Hájek R.

Vnitr Lek. 2010 Feb;56(2):138-48. Review. Czech.

PMID:
20329585
17.

Role of (99m)Tc-MDP bone scan in the diagnosis of Erdheim-Chester disease.

Mukherjee A, Damle N, Bal C, Arora A, Singhal A, Tripathi M, Peepre K.

Indian J Nucl Med. 2014 Jul;29(3):165-7. doi: 10.4103/0972-3919.136575.

18.

¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.

Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.

Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14. Review.

PMID:
25218739
19.

F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease.

Ambrosini V, Savelli F, Merli E, Zompatori M, Nanni C, Allegri V, Fanti S.

Clin Nucl Med. 2012 Feb;37(2):196-7. doi: 10.1097/RLU.0b013e31823e9d54.

PMID:
22228352
20.

Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.

Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.

Ann Oncol. 2015 Oct;26(10):2113-8. doi: 10.1093/annonc/mdv289. Epub 2015 Jul 22.

Supplemental Content

Support Center